Attribution, cognition and psychopathology in persistent insomnia disorder: outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy

Espie, Colin A.; Kyle, Simon D.; Miller, Claramae H.; Ong, Jason C.; Hames, Peter; Fleming, Leanne

doi:10.1016/j.sleep.2014.03.001

Cited by 82 publications

(48 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a randomized trial, published in 2012, Espie and his colleagues found that insomniacs using Sleepio reported greater gains in sleep efficiency -the percentage of time someone is asleep, out of the total time he or she spends in bed -and slightly larger improvements in daytime functioning than those using the placebo app 15 . In a follow-up 2014 paper 16 , they reported that Sleepio also reduced the racing, intrusive thoughts that can often interfere with sleep.…”

Section: Good Practicementioning

confidence: 99%

Mental health: There’s an app for that

Anthes¹

2016

Nature

315

191

View full text Add to dashboard Cite

Section: Good Practicementioning

confidence: 99%

Mental health: There’s an app for that

Anthes¹

2016

Nature

315

191

View full text Add to dashboard Cite

“…We used Pub-Med's controlled vocabulary terms (MeSH) and Medline's multi-field search for insomnia AND treatment, insomnia AND management, and insomnia AND therapy as well as the individual keywords sedatives, hypnotics, CBT-I, mindfulness, meditative movement, zolpidem, benzodiazepines, eszopiclone, doxepin, orexin, suvorexant, sleep tracking devices, insomnia treatment, and personal activ- efficiency or the percentage of time asleep out of time spent in bed, fatigue, mood, and overall daytime functioning. [53][54][55][56] The largest of these RCTs looked at 164 adults with chronic insomnia who were randomized to one of three arms: cCBT-I, imagery relief therapy (IRT: placebo), or treatment as usual (TAU). A sustained improvement in sleep efficiency was seen after six weeks of treatment with cCBT-I (20%) compared with TAU (6%; Cohen's d=0.95) and IRT (6%; Cohen's d=1.06), and this improvement was maintained eight weeks after treatment ended (20% v 7% for IRT (Cohen's d=1.00) and 9% for TAU (Cohen's d=0.69)).…”

Section: Sources and Selection Criteriamentioning

confidence: 99%

Advances in the management of chronic insomnia

Kay-Stacey

Attarian

2016

BMJ

122

View full text Add to dashboard Cite

Chronic insomnia is a common condition that affects people worldwide and has negative effects on patients' health and wellbeing. The treatment of insomnia can be complex and time consuming for patients and providers. Although behavioral interventions are the first line therapy, there are barriers to access for these treatments. However, in recent years, alternative ways of providing these behavioral therapies that make them more widely available have been investigated. Drugs also play an important role in the treatment of insomnia and new drugs have been introduced as options for treating patients with sleep initiation and sleep maintenance insomnia. In this review, we will discuss advances in the past six years in both non-pharmacologic and pharmacologic treatments for patients with chronic insomnia. We will also review the controversies surrounding some of the current drug treatments, as well as the role that technology and personal activity monitoring devices may play in treating insomnia.

show abstract

“…Optimal timing of the intervention is an important consideration-delivery is usually limited to when most individuals are just starting CPAP, and booster sessions to support longterm nightly use of what is often a lifelong treatment, though necessary, are rarely ongoing. Individualised health tracking through the use of Webbased and smartphone apps is likely to play a more prominent role in delivering future CPAP interventions and in providing behavioural feedback and measuring effectiveness, with online CBT shown to be effective in the treatment of insomnia [86]. Recently, severe OSA patients who regularly used a mobile health technology app BAPPnea^aimed at promoting self-monitoring of treatment had higher CPAP adherence [87].…”

Section: Conclusion/discussionmentioning

confidence: 99%

An Update on Behavioural Interventions for Improving Adherence with Continuous Positive Airway Pressure in Adults

D'Rozario

Galgut

Bartlett

2016

Curr Sleep Medicine Rep

View full text Add to dashboard Cite

Obstructive sleep apnoea (OSA) is a common sleep disorder which if left untreated results in considerable physical and psychological co-morbidity and mortality. With the development of continuous positive airway pressure (CPAP), an effective treatment was available to counteract the partial and complete airway closures, hypoxia and sleep fragmentation. Technological advances in CPAP devices improved the interface between machine and man, reduced noise levels and improved many aspects of the treatment process. Yet, with all these advancements over the last 35 years, adherence to CPAP remains low. There are a number of underlying factors in the poor uptake and discontinuation of treatment. Previous CPAP adherence interventions are discussed along with behavioural programmes which have emerged in the last 3 years. Of importance are the insights gained from emerging qualitative research in this area to enable a better understanding of patient perceptions and how these continue to impact on adherence rates.

show abstract

Attribution, cognition and psychopathology in persistent insomnia disorder: outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy

Cited by 82 publications

References 12 publications

Mental health: There’s an app for that

Mental health: There’s an app for that

Advances in the management of chronic insomnia

An Update on Behavioural Interventions for Improving Adherence with Continuous Positive Airway Pressure in Adults

Contact Info

Product

Resources

About